Aureus Greenway Holdings Inc (AGH): Nasdaq/NYSE listing notice — Nasdaq warns Aureus Greenway on equity, MVLS or net income deficiency; 180-day cure

Aureus Greenway Holdings Inc

Received Nasdaq notice on April 23, 2025 for failing minimum stockholders' equity ($2.5M), MVLS ($35M), or net income ($500K) requirements.
Company has until October 20, 2025 to regain compliance by achieving MVLS >= $35M for ten consecutive business days.
Notice is a deficiency notification; trading on Nasdaq Capital Market continues during the cure period.
Company will monitor MVLS and evaluate options to satisfy listing standards.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Aureus Greenway Holdings Inc received a nasdaq noncompliance notice notice regarding stockholders equity (rules 5550(b)(1), 5550(b)(2), 5550(b)(3)).

Exchange: nasdaq
Notice: noncompliance notice
Deficiency: stockholders equity
Rules: 5550(b)(1), 5550(b)(2), 5550(b)(3)

Exact text from the filing

April 23, 2025, Aureus Greenway Holdings Inc.(the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the Company did not comply with the minimum $2.5 million stockholders’ equity, $35 million market value of listed securities (“MVLS”), or $500,000 of net income from continuing operations requirements for continued listing on The Nasdaq Capital Market as set forth in Nasdaq Listing Rules 5550(b)(1), 5550(b)(2), or 5550(b)(3), respectively. The Notice is only a notification of deficie

View on SEC.gov

Browse all listing & compliance notices →

Aureus Greenway Holdings Inc filing history →

Source: SEC EDGAR

accession 0001641172-25-006221

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.